AbbVie is a research-based biopharmaceutical company. Co.'s products are focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus and human immunodeficiency virus; neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; as well as other serious health conditions. Co. has medicines in clinical development across immunology, oncology and neuroscience, with additional targeted investment in cystic fibrosis and women's health. We show 27 historical shares outstanding datapoints in our coverage of ABBV's shares outstanding history.
Understanding the changing numbers of ABBV shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like ABBV versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching ABBV by allowing them to research ABBV shares outstanding history
as well as any other stock in our coverage universe. |
Video: Shares Outstanding Importance
